Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction during and prior to availability of an in-house STEMI system: early experience and intermediate outcomes of the HARRT program for achieving routine D2B times <60 minutes.
Nguyen B, Fennessy M, Leya F, Nowak W, Ryan M, Freeberg S, Gill J, Dieter RS, Steen L, Lewis B, Cichon M, Probst B, Jarotkiewicz M, Wilber D, Lopez JJ. Nguyen B, et al. Among authors: gill j. Catheter Cardiovasc Interv. 2015 Aug;86(2):186-96. doi: 10.1002/ccd.25769. Epub 2015 Feb 25. Catheter Cardiovasc Interv. 2015. PMID: 25504976
Lessons Learned from STEMI Clinical Trials.
Gill J, Amin A, Parekh N, Nanjundappa A, Dieter RS. Gill J, et al. Interv Cardiol Clin. 2012 Oct;1(4):401-407. doi: 10.1016/j.iccl.2012.06.013. Epub 2012 Oct 5. Interv Cardiol Clin. 2012. PMID: 28581958 Review.
Ten-year perspective on interventional vascular therapy.
Gill J, O'Keefe C, Bufalino D, Weber B, Dieter RS. Gill J, et al. Expert Rev Cardiovasc Ther. 2013 May;11(5):521-4. doi: 10.1586/erc.13.53. Expert Rev Cardiovasc Ther. 2013. PMID: 23621132 No abstract available.
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group. Jensen TO, et al. Lancet Microbe. 2024 May 27:S2666-5247(24)00015-6. doi: 10.1016/S2666-5247(24)00015-6. Online ahead of print. Lancet Microbe. 2024. PMID: 38815595 Free article.
Hypertension and Kidney Function After Living Kidney Donation.
Garg AX, Arnold JB, Cuerden MS, Dipchand C, Feldman LS, Gill JS, Karpinski M, Klarenbach S, Knoll G, Lok CE, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Sontrop JM, Storsley L, Boudville N. Garg AX, et al. Among authors: gill js. JAMA. 2024 May 23:e248523. doi: 10.1001/jama.2024.8523. Online ahead of print. JAMA. 2024. PMID: 38780499
3,248 results